Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. (Q40902950)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

M Ikeda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Nozaki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K Sugiyama

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Tanaka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K Tanaka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H Sekihara

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K Shimotohno

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Saito

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Kato

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

51-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

Identification of the bactericidal domain of lactoferrin

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Lactoferrin: a multifunctional immunoregulatory protein?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Inhibition with lactoferrin of in vitro infection with human herpes virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Hepatitis G virus replication in human cultured cells displaying susceptibility to hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Lactoferrin inhibits cholesterol accumulation in macrophages mediated by acetylated or oxidized low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Problem hepatitis viruses: the mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Long-term human T-cell culture system supporting hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Single-step reverse transcription-polymerase chain reaction for the detection of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Binding of hepatitis C virus to CD81

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

The hepatitis C virus: overview

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Concentration of lactoferrin and transferrin throughout lactation in cow's colostrum and milk

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

A novel sequence found at the 3' terminus of hepatitis C virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Characterization of the chylomicron‐remnant‐recognition sites on parenchymal and Kupffer cells of rat liver Selective inhibition of parenchymal cell recognition by lactoferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2899%2900121-5

7 January 2021

10.1016/S0168-1702(99)00121-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653917%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference